Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ltd V.AVE


Primary Symbol: AVEFF

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Bullboard Posts
Post by Just2017on Sep 21, 2017 7:07pm
207 Views
Post# 26728443

Refurbishment Program is Next Bulls-Eye for Aveda

Refurbishment Program is Next Bulls-Eye for Avedahttps://www.stockhouse.com/opinion/interviews/2017/09/21/refurbishment-program-next-bulls-eye-for-aveda

"Over the last four quarters we got seven million dollar improvement quarter over quarter. Then in our most recent quarter, we had about a nine million improvement when we compared the same quarters to the previous year.

Our actual target market is going to depend on which base we are talking about in particular. But I guess in broad terms in general we work for large drilling contractors. Same way with the operators; large, small operators, large independents, medium independents. A long list of blue chip customers to the likes of HMP, Nabors, Chevron, Shell, Precision, Trinidad, the list goes on and on.

We’re really excited about our refurbishment program, I think it’s going to be great to see more of our kit get on the road and a higher utilization of our assets, less dependence on our third parties and I think that will really set us up for 2018 and really improve our profitability as we navigate through 2018."
Bullboard Posts